Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting | Zendy

Ali Kaya | Zendy; Emre Tekgündüz | Zendy; Fazılet Duygu | Zendy; Dicle Koca | Zendy; Filiz Bekdemir | Zendy; Hikmetullah Batgi | Zendy; Bahar Ulu Uncu | Zendy; Tuğçe Nur Yiğenoğlu | Zendy; Mehmet Sinan Dal | Zendy; Merih Çakar Kızıl | Zendy; Fevzi Altuntaş | Zendy

Open Access

Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting

Author(s) -

Ali Kaya,

Emre Tekgündüz,

Fazılet Duygu,

Dicle Koca,

Filiz Bekdemir,

Hikmetullah Batgi,

Bahar Ulu Uncu,

Tuğçe Nur Yiğenoğlu,

Mehmet Sinan Dal,

Merih Çakar Kızıl,

Fevzi Altuntaş

Publication year - 2017

Publication title -

balkan medical journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.398

H-Index - 16

eISSN - 2146-3131

pISSN - 2146-3123

DOI - 10.4274/balkanmedj.2016.0012

Subject(s) - medicine , febrile neutropenia , neutropenia , transplantation , hematopoietic stem cell transplantation , haematopoiesis , antibiotics , stem cell , intensive care medicine , surgery , chemotherapy , biology , microbiology and biotechnology , genetics

Haematopoietic stem cell transplantation is a curative treatment option for many haematological disorders. Infection following haematopoietic stem cell transplantation is one of the major causes of mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research